| Website | xlumena.com |
| Category | Consumer Electronics/Devices |
| Phone | 650.961.9900 |
| info@xlumena.com | |
| Employees |
| TOTAL | $7M |
| FUNDING TOTAL | $7M |
| Series B, 4/11 Aperture Venture Partners Western Technology Investment Charter Life Sciences Ascent Biomedical Ventures Prism Venture Management | $7M |
Xlumena Inc. develops image-guided therapeutic endoscopy products. It develops Bile Duct Stenting, a self-expanding anchor stent and precision XL delivery system; Translumenal Access for Translumenal delivery of endoscopic instruments and devices using the integrated Exchange Free (XF) delivery system; Gallbladder Drainage that drains the gallbladder into the duodenum or stomach using a lumenal approximating stent and precision delivery system; and Bile and Pancreatic Duct Drainage, which creates an anastomotic bypass to drain the bile ducts or pancreatic ducts into the duodenum using the integrated XF delivery system, lumenal approximation tools, and novel anchor stent. The company also develops Pseudocyst Drainage, an integrated XF system designed to enable reliable pseudocyst drainage; and Hiatal Hernia Repair that enables the repair of a hiatal hernia from inside the GI lumen. Xlumena Inc. was founded in 2007 and is based in Mountain View, California.
